# A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

> clinical trial · VERIFIED · 2026-06-12

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Colitis Ulcerative

- Company: Merck Sharp & Dohme LLC
- Sector: gastroenterology
- Primary source: https://clinicaltrials.gov/study/NCT07463183

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.